These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Expanding the spectrum of neuromyelitis optica: friend or foe? Behbehani R Curr Opin Ophthalmol; 2007 Nov; 18(6):459-62. PubMed ID: 18162996 [TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica. Weinstock-Guttman B; Miller C; Yeh E; Stosic M; Umhauer M; Batra N; Munschauer F; Zivadinov R; Ramanathan M Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis. Warabi Y; Yagi K; Hayashi H; Matsumoto Y J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825 [TBL] [Abstract][Full Text] [Related]
15. Interferon-beta(1b) treatment in neuromyelitis optica. Tanaka M; Tanaka K; Komori M Eur Neurol; 2009; 62(3):167-70. PubMed ID: 19590215 [TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica and asian phenotype of multiple sclerosis. Kira J Ann N Y Acad Sci; 2008 Oct; 1142():58-71. PubMed ID: 18990121 [TBL] [Abstract][Full Text] [Related]